Free Trial
TSE:ASP

Acerus Pharmaceuticals (ASP) Stock Price, News & Analysis

Acerus Pharmaceuticals logo

About Acerus Pharmaceuticals Stock (TSE:ASP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1,250 shs
Average Volume
4,719 shs
Market Capitalization
C$2.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASP Stock News Headlines

Acerus Update
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
IIROC Trading Halt - ASP
Acerus Files For CCAA Protection
Acerus: Q3 Earnings Snapshot
See More Headlines

ASP Stock Analysis - Frequently Asked Questions

Shares of ASP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acerus Pharmaceuticals investors own include Aurora Cannabis (ACB), Surna (SRNA), Allena Pharmaceuticals (ALNA), Molecular Templates (MTEM), Absolute Software Co. (ABT.TO) (ABT), Achieve Life Sciences (ACHV) and Algonquin Power & Utilities (AQN).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:ASP
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($4.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$28.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-54.10%

Debt

Debt-to-Equity Ratio
261.01
Current Ratio
0.67
Quick Ratio
0.26

Sales & Book Value

Annual Sales
C$3.04 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.29
Book Value
C($1.80) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,710,000
Free Float
N/A
Market Cap
C$2.78 million
Optionable
Not Optionable
Beta
1.03
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (TSE:ASP) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners